
Six Policy Actions to Help Medicare-Medicaid Enrollees Get Better Care
LDI Fellows Outline a Path Forward Based on Lessons From the Last Decade
In Their Own Words
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.
LDI Fellows Outline a Path Forward Based on Lessons From the Last Decade
Paying More For Primary Care Showed Dramatic Results, LDI Fellow Found
A Penn LDI Virtual Seminar Analyzes What Program Elements Congress Might Kill
As Congress Considers Cuts to Medicaid Spending, Policymakers Should Better Account for States’ Ability to Pay
Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
LDI Expert Insights and Key Takeaways from Select Publications